RESTORING P53 TUMOR SUPPRESSION
Treatments targeting genome guardian p53-loss or mutation in cancer with small molecules that use p73 or integrated stress response.
P53-Therapeutics, Inc.
p53-Therapeutics, Inc. is developing a new class of small molecule cancer therapeutics to effectively bypass mutations in the p53 tumor suppressor gene to treat patients with cancer.
Our Focus
Targeting tumors with mutated p53
p53-Therapeutics uses a novel approach with candidate drugs that biochemically and functionally modulate the most important cancer pathway.
Get In Touch with P53-Therapeutics, Inc.
Learn about technology and collaborate in our drug development program.
OUR EXPERTISE
Clinical Oncology
Cancer Therapeutics
Tumor Suppressor Genes
Precision Oncology
Genomic Medicine
Drug Resistance
Clinical Oncology
Clinical Oncology
Improve patient outcomes and quality of life.
Cancer Therapeutics
Cancer Therapeutics
Bring effective new treatments and combinations to patient with cancer.
Tumor Suppressor Genes
Tumor Suppressor Genes
Harness the power of the body’s p53 tumor suppressor mechanism with new treatments.
Precision Oncology
Precision Oncology
Develop combination treatments that address each patient’s individual tumor.
Genomic Medicine
Genomic Medicine
Use advanced technologies including artificial intelligence in oncology.
Drug Resistance
Drug Resistance
Understand and develop therapeutic strategies to overcome aggressive drug resistant cancers.